Inflammatorische Kardiomyopathie und Myokarditis

Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry

(2017) Marc-Alexander Ohlow et al.   Journal of Cardiology

Dilated cardiomyopathy

(2017) Robert G Weintraub et al.   LANCET

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

(2016) Heinz-Peter Schultheiss et al.   Clinical Research in Cardiology

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy

(2016) Felicitas Escher et al.   Clinical Research in Cardiology

Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature

(2016) Job Verdonschot et al.   EUROPEAN JOURNAL OF HEART FAILURE

Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy

(2016) Christian Besler et al.   EUROPEAN JOURNAL OF HEART FAILURE

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

(2016) Douglas B. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

2015 ESC Guidelines for the diagnosis and management of pericardial diseases

(2015) Yehuda Adler et al.   EUROPEAN HEART JOURNAL

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

(2013) A. L. P. Caforio et al.   EUROPEAN HEART JOURNAL

Ätiologie, Diagnose, Management und Therapie der Myokarditis

(2013) S. Pankuweit et al.   HERZ

Idiopathic giant cell myocarditis and cardiac sarcoidosis

(2012) Lori A. Blauwet et al.   HEART FAILURE REVIEWS

Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives

(2012) Bernhard Maisch et al.   HEART FAILURE REVIEWS

Molecular signatures and the study of gene expression profiles in inflammatory heart diseases

(2012) V. Ruppert et al.   HERZ

Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy

(2012) B. Maisch et al.   HERZ

2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

(2011) Ornella Leone et al.   CARDIOVASCULAR PATHOLOGY

Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis

(2011) Bettina Heidecker et al.   CIRCULATION

Virus serology in patients with suspected myocarditis: utility or futility?

(2011) F. Mahfoud et al.   EUROPEAN HEART JOURNAL

Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy

(2011) Peter Alter et al.   EUROPEAN JOURNAL OF HEART FAILURE

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

(2010) Robert Dennert et al.   ANTIVIRAL THERAPY

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

(2009) A. Frustaci et al.   EUROPEAN HEART JOURNAL

Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper

(2009) Matthias G. Friedrich et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Usefulness of Immunosuppression for Giant Cell Myocarditis

(2008) Leslie T. Cooper et al.   AMERICAN JOURNAL OF CARDIOLOGY